Sign In
Buy LUMO
$4.34
+0 (+0%)
At Close: Mar 10, 2025
Lumos Pharma Promotes John C. McKew, PhD to Chief Operating Officer and Chief Scientific Officer
08:05pm, Thursday, 02'nd Apr 2020
Lumos Pharma, Inc. (LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced the promotion of John C. McKew, PhD to the position of Chief Operating Office
Global Immune Checkpoint Inhibitors Market Outlook 2022
06:15pm, Wednesday, 01'st Apr 2020
The "Global Immune Checkpoint Inhibitors Market Outlook 2022" report has been added to ResearchAndMarkets.com's offering.
Outlook on the Worldwide Immune Checkpoint Inhibitors to 2022 - Featuring CureTech, NewLink Genetics & Novartis Among Others
08:08am, Wednesday, 01'st Apr 2020
Dublin, April 01, 2020 -- The "Global Immune Checkpoint Inhibitors Market Outlook 2022" report has been added to ResearchAndMarkets.com's offering. Given the.
Stop Chasing Coronavirus Plays Like Moderna Stock
10:10am, Wednesday, 25'th Mar 2020
Stocks like MRNA stock have soared on hopes they will benefit from the coronavirus pandemic. But history shows few, if any, actually will.
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be
STOCKS IN THE NEWS
08:15pm, Friday, 20'th Mar 2020
NEW YORK (AP) — Changes announced in corporate dividends: INCREASED DIVIDENDS Benchmark Electronics .16 from .15 Cousins Properties .30 from .29 Guaranty Bancshares .19 from .18 Independent Bank Cor
